People · Operator
Named in public records as an officer, director or promoter · active 2018–2022 · Healthtech, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Asenda Health Inc. | — | Healthtech | Seed | $5.0M | $19.1M | 2022 |
| Zenabis Global Inc. | — | Other | Seed | $4.0M | $57.8M | 2019 |
| Sun Pharm Investments Ltd. | — | Other | Pre-Seed | $422K | $9.8M | 2018 |
Manoj Sikka at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Manoj Sikka on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Mark Catroppa | 3 | 3 |
| Daniel Burns | 1 | 5 |
| LEO BENNE | 1 | 2 |
| John Hoekstra | 1 | 2 |
| Andrew Grieve | 1 | 1 |
| Larry Van Wieren | 1 | 1 |
| Mike O. McGinty | 1 | 1 |
| John O. Hoekstra | 1 | 1 |
| Rick O. Brar | 1 | 1 |
| Daniel O. Burns | 1 | 1 |
| Leo O. Benne | 1 | 1 |
| Larry O. Van Wieren | 1 | 1 |
| Donald O. Fairholm | 1 | 1 |
| Kevin Coft | 1 | 1 |
| Jodhvir Sarai | 1 | 1 |
| Karim Salamatian | 1 | 1 |
| Adam Spears | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.